DYRK1A and Alzheimer disease: Finally, several reports have indicated that the progression of tau pathology in DS occurs subsequently from the early-life accumulation of intracellular APP metabolites, but on a more rapid timeframe than in AD, possibly due to excessive tau phosphorylation by DYRK1A and RCAN1-gain of function [71].